Chłopiec chory na SMA

EN_01552308_0010
Chłopiec chory na SMA
Levi de Oliveira Balbino, 2, who received an infusion of Zolgensma, a cutting edge gene therapy for his spinal muscular atrophy (SMA) that can cost more than $1 million, at his home outside of Recife, Brazil, June, 4, 2022. A wave of transformative but hugely expensive treatments is challenging the budgets of health coverage systems in both wealthy nations and some countries with far fewer resources. (Dado Galdieri/The New York Times)
Minimum price 100USD
2022-06-04
DADO GALDIERI/The New York Times Agency/East News
The New York Times Agency
DADO GALDIERI
15793698
5,28MB
42cm x 28cm przy 300dpi
1, 2, 2022, 4, A, AMERICA, AN, AND, AT, ATROPHY, BALBINO, BOTH, BRAZIL, BUDGETS, BUT, CAN, CHALLENGING, COST, COUNTRIES, COVERAGE, CUTTING, DADO, DE, DISEASE, DISORDER, EDGE, EXPENSIVE, FAR, FEWER, FOR, GALDIERI, GENE, GENETIC, GOVERNMENT, HEALTH, HIS, HOME, HUGELY, IN, INFUSION, IS, JUNE, LEVI, MEDICAL, MEDICATIONS, MILLION, MORE, MUSCULAR, NATIONS, NEW, OF, OLIVEIRA, OUTSIDE, PRICE, RARE, RECEIVED, RECIFE, RESOURCES, SMA, SOME, SOUTH, SPINAL, SYSTEMS, THAN, THAT, THE, THERAPIES, THERAPY, TIMES, TRANSFORMATIVE, TREATMENTS, WAVE, WEALTHY, WHO, WITH, YORK, ZOLGENSMA,